Skip to main content

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Judge Rejects Ethicon's Plea to Dismiss 120 TVM Lawsuits

Introduction

Ethicon Inc. had requested a Pennsylvania State Court Judge Arnold New to exclude 120 Transvaginal Mesh (TVM) lawsuits from Mass tort proceedings, stating that the venue is improper since the plaintiffs do not belong to Pennsylvania.

The Supreme Court's recent decision which allows plaintiffs to file a lawsuit in the jurisdiction where the defendant is headquartered or where the injury has allegedly occurred was the reason for Ethicon to make this move. However, in an order dated May 18, the Judge denied the plea as an “integral portion” of Ethicon Pelvic mesh device was manufactured by Secant Medical Inc., a Pennsylvania-based manufacturer. 

Judge Arnold further clarified,  “since a portion of the manufacturing process of the Gynemesh/Gynemesh PS, Prolene, Prolift, Prosima, TVT, TVT-Exact, TVT-Obturator and TVT-Secur Pelvic mesh medical devices occurs in Pennsylvania, this court’s exercise of specific personal jurisdiction comports with traditional notions of fair play and substantial justice.”

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!